Skip to main content


Latest articles

30-04-2021 | Diabetes | News | Article

Inequities in access to SGLT2 inhibitor therapy uncovered

Results from a US retrospective study suggest that usage rates of SGLT2 inhibitors remain low in people with type 2 diabetes, particularly among Black and Asian individuals, women, and lower-income groups.

29-04-2021 | Diabetes | News | Article

Liver, pancreatic fat may underlie ‘disproportionately raised’ CV risk in women with diabetes

Women naturally have lower levels of hepatic and pancreatic fat than men, but having type 2 diabetes removes this advantage and confers a relatively larger increase in cardiovascular risk, show further data from DiRECT.

28-04-2021 | Diabetes | News | Article

Blood pressure, lipids may contribute to long-term dementia risk in type 2 diabetes

The onset of dementia in people with type 2 diabetes may be foreshadowed by elevated levels of some vascular risk factors 1 to 2 decades beforehand, say researchers.

27-04-2021 | Diabetes | News | Article

Dementia added to list of early-onset diabetes dangers

Research published in JAMA suggests the risk for dementia increases with younger age at type 2 diabetes diagnosis, with the risk further increased in people who have a stroke.

23-04-2021 | Diabetes | News | Article

Pragmatic trial challenges ‘dogma’ of basal–bolus insulin for advanced type 2 diabetes

Combining a GLP-1 receptor agonist or SGLT2 inhibitor with basal insulin allows people with type 2 diabetes on a basal–bolus regimen to drop the prandial insulin, shows the pragmatic BEYOND trial.

22-04-2021 | Diabetes | News | Article

Real-world DISCOVER program highlights sulfonylurea drawbacks

Combining metformin with a sulfonylurea produces poorer non-glycemic outcomes than combining it with other second-line agents, show results from the global DISCOVER program.

21-04-2021 | Diabetes | News | Article

Metformin may reduce pneumonia risk

Researchers have found that people taking metformin for type 2 diabetes are less likely to be hospitalized or die due to pneumonia than those taking other glucose-lowering medications.

20-04-2021 | Diabetes | News | Article

Routine autoantibody measurement advised for suspected adult type 1 diabetes

A majority of adults with clinically diagnosed type 1 diabetes but no islet autoantibodies have a low genetic risk for the condition, suggesting misdiagnosis, report researchers.

20-04-2021 | Diabetes | News | Article

Straightforward ultrasound measurement may predict gestational diabetes

Visceral adipose tissue depth measured during the first trimester of pregnancy predicts gestational diabetes better than current clinical indicators, research suggests.

20-04-2021 | Diabetes | News | Article

Trigger finger may warn of impending CVD complications in type 2 diabetes

People with type 2 diabetes who have trigger finger are likely at an increased risk for cardiovascular disease, say researchers.

16-04-2021 | Diabetes | News | Article

Large study illustrates efficacy of Loop DIY automated insulin delivery

A large real-world study shows improved glycemic outcomes for adults and children who initiate use of the Loop DIY automated insulin delivery system using community resources.

16-04-2021 | Diabetes | News | Article

Familial, sporadic type 1 diabetes are ‘overall similar’

Children with familial type 1 diabetes have different characteristics to those with sporadic diabetes at presentation, but longer-term outcomes are similar, say researchers.

15-04-2021 | Diabetes | News | Article

Hyperglycemia aversiveness linked to increased hypoglycemia exposure

People with type 1 diabetes who are “hyperglycemia aversive” reduce their hyperglycemia exposure at the cost of increased hypoglycemia and, potentially, reduced hypoglycemia awareness, research suggests.

14-04-2021 | Diabetes | News | Article

Psychologic wellbeing may influence type 2 diabetes glucose control during COVID-19 lockdown

COVID-19 restrictions do not significantly impact glycated hemoglobin levels in individuals with type 2 diabetes, but those with poor psychologic wellbeing may experience worsening glycemic control, suggest findings from an Italian study.

13-04-2021 | Diabetes | News | Article

DAPA-HF: Consistent benefits of dapagliflozin in men and women

Adding dapagliflozin to standard care improves outcomes for people with heart failure and reduced ejection fraction irrespective of sex, suggests a prespecified subgroup analysis of the DAPA-HF trial.

12-04-2021 | Diabetes | News | Article

Changes in vasoactive mediators may contribute to dapagliflozin benefits

Findings from a US randomized controlled trial suggest that add-on treatment with the SGLT2 inhibitor dapagliflozin reduces levels of some vasoconstrictors and increases some vasodilators in people with type 2 diabetes.

09-04-2021 | Diabetes | News | Article

Ethnicity may be independently linked to beta-cell function

Black West African men have lower levels of insulin secretion in response to a meal than their White Northern European counterparts, irrespective of insulin sensitivity, study findings indicate.

08-04-2021 | Diabetes | News | Article

Genetic analysis backs causal link between blood glucose and stroke

A Mendelian analysis supports a causal effect of hyperglycemia on stroke risk, and the researchers also pinpoint the medications most likely to reduce this risk.

07-04-2021 | Diabetes | News | Article

Real-world data support benefits of flash glucose monitoring

Flash glucose monitoring is associated with small but sustained improvements in glycemic control and a reduction in severe hypoglycemia relative to self-monitoring of blood glucose in type 1 diabetes, observational data show.

06-04-2021 | Diabetes | News | Article

Fear more than reality of hypoglycemia impacts QoL in adolescents

Fear of hypoglycemia, rather than the actual frequency of hypoglycemic events, may impact diabetes-specific quality of life in adolescents, say researchers.